Systemic treatment of bone metastases from breast cancer: Is it all that it's cracked up to be? [7]

Journal of Clinical Oncology

Volumn 23, Issue 21, 2005, Pages 4802-4803

  Gainford, Mary C ^a   Dranitsaris, George ^a   Clemons, Mark ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; TELOPEPTIDE;

BONE METASTASIS; BONE PAIN; BREAST CANCER; DRUG EFFECT; FOLLOW UP; HUMAN; IMAGING SYSTEM; LETTER; NERVE ROOT COMPRESSION; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; SPINAL CORD COMPRESSION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; BONE TUMOR; BREAST TUMOR; FEMALE; METASTASIS; NOTE; PATHOLOGY;

BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS;

EID: 23044447886     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.3490     Document Type: Letter

References (6)

1. Hamaoka T, Madewell JE, Podoloff DA, et al: Bone imaging in metastatic breast cancer. J Clin Oncol 22:2942-2953, 2004
2. Clemons M, Rea D: Perspectives on the future of bisphosphonate use in breast cancer patients. Semin Oncol 31:87-91, 2004 (suppl 10)
3. Verma S, Kerr-Cresswell D, Dranitsaris G, et al: Bisphosphonate use for the management of breast cancer patients with bone metastases: A survey of Canadian Medical Oncologists. Support Care Cancer 12:852-858, 2004
4. Clemons M, Enright K, Cesta A, et al: Do physicians follow systemic treatment and funding policy guidelines? Can J Clin Pharmacol 11:e168-e178, 2004
5. Brown J, Thompson C, Ellis S, et al: Bone resorption predicts for skeletal complications in metastatic bone disease. Br J Cancer 89:2031-2037, 2003
6. Clamp A, Danson S, Nguyen H, et al: Assessment of therapeutic response in patients with metastatic bone disease. Lancet Oncol 5:607-616, 2004